WallStSmart
COEP

Coeptis Therapeutics Inc

NASDAQ: COEP · HEALTHCARE · BIOTECHNOLOGY

$16.40
+1.17% today

Updated 2026-04-24

Market cap
$102.06M
P/E ratio
—
P/S ratio
74.88x
EPS (TTM)
$-2.81
Dividend yield
—
52W range
$7 – $21
Volume
0.0M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Coeptis Therapeutics Inc (COEP) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item2004200520182019202020212022202320242025
Revenue————$30761.00$75000.00$0.00$0.00$0.00$1.36M
Revenue growth (YoY)—————+143.8%-100.0%———
Cost of revenue————$964217.00$447413.00$1.00M$1.00M$1.04M$4.20M
Gross profit————$-933456.00$75000.00$-1.00M$-1.00M$-1.04M$-2.83M
Gross margin————-3034.5%100.0%———-207.8%
R&D————$3543.00$3543.00$20887.00$6.67M$2.33M$1.28M
SG&A————$5.77M$14.12M$34.17M$3.95M$945641.00$1.15M
Operating income$-10077.00$-308000.00——$-6.86M$-14.05M$-34.20M$-21.49M$-10.05M$-13.04M
Operating margin————-22305.5%-18727.9%———-956.9%
EBITDA$2.65M$-344000.00$-7070.00$171860.00$-8.68M$-12.81M$-36.35M$-20.16M$-9.44M$-11.82M
EBITDA margin————-28232.7%-17086.3%———-867.2%
EBIT$-10077.00$-308000.00$-1.89M$0.00$-9.01M$-13.26M$-37.36M$-21.16M$-10.48M$-13.04M
Interest expense——$0.00$0.00$148192.00$187133.00$218412.00$107685.00$396116.00$642379.00
Income tax——————————
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$2.65M$-344000.00$-7073.00$-2234.00$-9.16M$-13.45M$-37.57M$-21.27M$-10.88M$-11.92M
Net income growth (YoY)—-113.0%+97.9%+68.4%-409760.6%-46.9%-179.4%+43.4%+48.9%-9.6%
Profit margin————-29765.9%-17932.4%———-874.3%